Michael Goodman, M.D., F.A.C.P., Curriculum Vitae - Glacier Oncology

Staff Liaison, Division of Animal Resources, Scripps Clinic and Research Foundation, La Jolla,California, April 1986-1992Committees (continued)Member, Animal Research Committee, Scripps Clinic and Research Foundation, 1986-1992Member, Nonhuman Primate Research Committee, Scripps Clinic and Research Fdn 1986-92Reviewer, Advisory Committee, Medical Biochemistry Study Section, National Institutes ofHealth, 1987,1988Reviewer, National Science Foundation, 1982Reviewer, Arthritis Society of Canada, 1985-1996Advisor, World Health Organization, Geneva, Switzerland, 1990Member, Clinical Protocol Committee, Scripps Clinic and Research Foundation, 1992-1996National Cancer Institute Site Visit Committee Member, Advisory Committee, National Institutesof Health, 1994-1996.Member, Clinical Protocol Committee, Kalispell Regional Medical Center, Kalispell, MT, 1997-presentMember, Radiation Oncology Review Commitee, Kalispell Regional Med Center, Kalispell, MTChief, Section of Oncology, Kalispell Regional Medical Center, Kalispell, MT, 1997-1999Member, Kalispell Regional Medical Center General Tumor Board, 2010 -presentMember, Kalispell Regional Medical Center Breast Tumor Board, 2010 - presentClinical Trials Designed1. A Phase I study of the safety, pharmacokinetics and immunologic effects of loxoribine (7-allyl-8-oxoguanosine) in patients with advanced malignancies who have failed standard therapy. B.Meisenberg, D.L. McKee, M.G. Goodman. Scripps Clinic and Research Fdn.2. Loxoribine—a phase I/II study of the safety, pharmacokinetics, and immunologic effects inpatients with advanced, previously treated chronic lymphocytic leukemia. M.P Kosty, L.D.Piro, and M.G. Goodman. Scripps Clinic and Research Foundation.